Misobit (Glyset)25mg 100 tablet

$44.90

Each Misobit contains 25 mg Miglitol 100 tablets. It is used to lower blood sugar in patients with high blood sugar (diabetes).

ATC Classification: A10BF02
Active Ingrediant: Miglitol
Generic Name: Misobit
Manufacturer: Lupin Limited
Strength: 25mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 Tab

Out of stock

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Misobit (Glyset)25mg 100 tablet
$44.90

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Miglitol Information


What is this drug used for?

• It is used to lower blood sugar in patients with high blood sugar (diabetes).

 

Possible side effects

Miglitol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• Belly pain.
• Diarrhea.
• Gas.

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Low blood sugar can happen. The chance may be raised when this drug is used with other drugs for diabetes. Signs may be dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. Call your doctor right away if you have any of these signs. Follow what you have been told to do for low blood sugar. This may include taking glucose tablets, liquid glucose, or some fruit juices.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Glyset may be confused with Cycloset

Miglitol may be confused with migalastat, miglustat

 

Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

 

Adverse Reactions

>10%: Gastrointestinal: Flatulence (42%), diarrhea (29%), abdominal pain (12%)

1% to 10%: Dermatologic: Skin rash (4%)

<1%, postmarketing, and/or case reports: Abdominal distention, gastrointestinal pain, intestinal obstruction, nausea, paralytic ileus, pneumatosis cystoides intestinalis –

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , ,

Strength

Dosage Type

Packaging Type